Improved Biomarker Set For Salivary Gland Tumor Diagnosis

  • Published: Jan 11, 2017
  • Earliest Priority: Jul 10 2015
  • Family: 2
  • Cited Works: 42
  • Cited by: 0
  • Cites: 0
  • Sequences: 7
  • Additional Info: Cited Works Sequence

The full document isn't yet available to us from the patent office.


The invention relates to a set of biomarkers for the diagnosis of salivary gland neoplasms wherein said set consists of at least four markers selected from the group of hsa-miR-449b, hsa-miR-374, hsa-miR-411, hsa-miR-599, hsa-miR-1285, hsa-miR-324-5p and hsa-miR-449a, a method for diagnosing the benign or malignant status of a salivary gland tumor and methods for screening for pharmaceuticals for the treatment of (malignant) salivary gland tumors.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jan 11, 2017
  • Application: Jul 10, 2015
    EP EP 15176290 A
  • Priority: Jul 10, 2015
    EP EP 15176290 A

Download Citation

Sign in to the Lens